Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 4, Number 4—December 1998

Chlamydia pneumoniae and Cardiovascular Disease

Lee Ann Campbell, Cho-Chou Kuo, and J. Thomas Grayston
Author affiliations: University of Washington, Seattle, Washington, USA

Main Article

Figure 1

Ultrastructural evidence of Chlamydia pneumoniae in coronary atheroma. This transmission electron micrograph demonstrates the presence of endosomes containing C. pneumoniae pear-shaped elementary bodies within a foam cell in tissue from coronary artery atheroma. Arrows in inset point to the elementary bodies. Bar=0.5 µm. (Reprinted from Journal of Infectious Diseases (8) with permission from the publisher, University of Chicago Press).

Figure 1. Ultrastructural evidence of Chlamydia pneumoniae in coronary atheroma. This transmission electron micrograph demonstrates the presence of endosomes containing C. pneumoniae pear-shaped elementary bodies within a foam cell in tissue from coronary artery atheroma. Arrows in inset point to the elementary bodies. Bar=0.5 µm. (Reprinted from Journal of Infectious Diseases (8) with permission from the publisher, University of Chicago Press).

Main Article

  1. Kuo  C-C, Jackson  LA, Campbell  LA, Grayston  JT. Chlamydia pneumoniae. Clin Microbiol Rev. 1995;8:45161.PubMedGoogle Scholar
  2. Saikku  P, Mattila  K, Nieminen  RS, Makela  PH, Huttunen  JK, Valtonen  V. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:9836. DOIPubMedGoogle Scholar
  3. Saikku  P, Leinonen  M, Tenkanen  L, Linnanmäki  E, Ekman  MR, Manninen  V, Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med. 1992;116:2738.PubMedGoogle Scholar
  4. Linnanmäki  E, Leinonen  M, Mattila  K, Nieminen  MS, Valtonen  V, Saikku  P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation. 1993;87:11304.PubMedGoogle Scholar
  5. Grayston  JT, Kuo  C-C, Campbell  LA, Wang  SP, Jackson  L. Chlamydia pneumoniae and cardiovascular disease. Cardiologia. 1997;42:114551.PubMedGoogle Scholar
  6. Danesh  J, Collins  R, Peto  R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:4306. DOIPubMedGoogle Scholar
  7. Kuo  C-C, Shor  A, Campbell  LA, Fukushi  H, Patton  DL, Grayston  JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993;167:8419.PubMedGoogle Scholar
  8. Kuo  C-C, Grayston  JT, Campbell  LA, Goo  YA, Wissler  RW, Benditt  EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young (15 to 35 year) adults. Proc Natl Acad Sci U S A. 1995;92:69114. DOIPubMedGoogle Scholar
  9. Campbell  LA, O'Brien  ER, Cappuccio  AL, Kuo  C-C, Wang  S-P, Stewart  D, Detection of Chlamydia pneumoniae (TWAR) in human coronary atherectomy tissues. J Infect Dis. 1995;172:5858.PubMedGoogle Scholar
  10. Davidson  M, Kuo  C-C, Middaugh  JP, Campbell  LA, Wang  SP, Finley  JC, Chlamydia pneumoniae (TWAR) in Alaska Natives with coronary atheroma. Circulation. 1998. In press.PubMedGoogle Scholar
  11. Ramirez  J, Ahkee  A, Ganzel  BL, Ogden  LL, Gaydos  CA, Quinn  TC, Isolation of Chlamydia pneumoniae (C pn) from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med. 1996;125:97982.PubMedGoogle Scholar
  12. Ouchi  K, Fuji  B, Kanamoto  Y, Miyazaki  H, Nakazawa  T. Detection of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries and large arteries. In: Abstracts of the 35th International Conference on Antimicrobial Agents and Chemotherapy; 1995; San Francisco, California. Abstract K-37.
  13. Mühlestein  JB, Hammond  EH, Carlquist  JF, Radicke  E, Thomson  MJ, Kargounis  LA, Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 1996;27:155561. DOIPubMedGoogle Scholar
  14. Varghese  PJ, Gaydos  CA, Arumugham  SB, Pham  DG, Quinn  TC, Tuazon  CU. Demonstration of Chlamydia pneumoniae in coronary atheromas specimens from young patients with normal cholesterol from the southern part of India. In: Abstracts of the 33rd Annual Meeting of the Infectious Disease Society of America; 1995; San Francisco, California; 1995. p. 53.
  15. Jackson  LA, Campbell  LA, Kuo  C-C, Lee  A, Grayston  JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis. 1997;176:2925. DOIPubMedGoogle Scholar
  16. Maass  M, Krause  E, Kruger  S, Engel  PM, Barels  C. Coronary arteries harbour viable C. pneumoniae [Abstract]. J Clin Infect. 1997;3(Suppl 2):136.
  17. Chiu  B, Viira  E, Tucker  W, Fong  IW. Chlamydia pneumoniae, cytomegalovirus and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997;86:2144-8. Kuo C-C, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb. 1992;13:15014.
  18. Juvonen  J, Juvonen  T, Laurila  A, Alakarppa  H, Lounatmaa  K, Surcel  HM, Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg. 1997;25:499505. DOIPubMedGoogle Scholar
  19. Blasi  F, Denti  F, Erba  M, Cosentini  P, Raccanelli  R, Rinaldi  A, Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol. 1996;34:27669.PubMedGoogle Scholar
  20. Ong  G, Thomas  BJ, Mansfield  OA, Davidson  BR, Taylor-Robinson  D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol. 1996;49:1026. DOIPubMedGoogle Scholar
  21. Kuo  C-C, Coulson  AS, Campbell  LA, Cappuccio  AL, Lawrence  RD, Wang  S-P, Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J Vasc Surg. 1997;26:13. DOIPubMedGoogle Scholar
  22. Juvonen  J, Juvonen  T, Laurila  A, Kuusisto  J, Bodai  CA, Alarakkola  E, Can degenerative tricuspid aortic valve stenosis be caused by a persistent Chlamydia pneumoniae infection? A study of 46 cadavers. Ann Intern Med. 1998. In press.PubMedGoogle Scholar
  23. Nystrom-Rosander  C, Thelin  S, Hjelm  E, Lindquist  O, Pahlson  C, Friman  G. High incidence of Chlamydia pneumoniae in sclerotic heart valve of patients undergoing aortic valve replacement. Scand J Infect Dis. 1997;29:3615. DOIPubMedGoogle Scholar
  24. Shor  A, Kuo  C-C, Patton  DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J. 1992;82:15861.PubMedGoogle Scholar
  25. Grayston  JT, Kuo  C-C, Coulson  AS, Campbell  LA, Lawrence  RD, Ming-Jong  L, Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation. 1995;92:3397400.PubMedGoogle Scholar
  26. Jackson  LA, Campbell  LA, Schmidt  RA, Kuo  C-C, Cappuccio  AL, Grayston  JT. Specificity of detection of Chlamydia pneumoniae in cardiovascular and non-cardiovascular tissues: evaluation of the innocent bystander hypothesis. Am J Pathol. 1997;150:178590.PubMedGoogle Scholar
  27. Weiss  SM, Roblin  PM, Gaydos  CA, Cummings  P, Patton  DL, Schulhoff  N, Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis. 1996;173:95796.PubMedGoogle Scholar
  28. Jang  IK, Lassila  R, Fuster  V. Atherogenesis and inflammation. Eur Heart J 1993;14 Suppl K:2-6.
  29. Grönhagen-Riska  M, Saikku  P, Riska  H, Froseth  B, Grayston  JT. Antibodies to TWARa novel type of Chlamydiain sarcoidosis. In: Grassi C, Rizzato G, Pozzi E, editors. Sarcoidosis and other granulomatous disorders. Amsterdam: Excerpta Medica; 1988. p. 297-301.
  30. Godzik  K, O'Brien  ER, Wang  S-W, Kuo  C-C. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol. 1995;33:24114.PubMedGoogle Scholar
  31. Gaydos  CA, Summersgill  JT, Sahney  NN, Ramirez  JA, Quinn  TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells and aortic artery smooth muscle cells. Infect Immun. 1996;64:161420.PubMedGoogle Scholar
  32. Kalayoglu  MV, Byrne  GI. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis. 1998;177:7259. DOIPubMedGoogle Scholar
  33. Yang  Y-S, Cummings  PK, Patton  DL, Kuo  C-C. Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice. J Infect Dis. 1994;170:4647.PubMedGoogle Scholar
  34. Moazed  TC, Kuo  CC, Grayston  JT, Campbell  LA. An experimental rabbit model of Chlamydia pneumoniae infection. Am J Pathol. 1996;148:66776.PubMedGoogle Scholar
  35. Moazed  TC, Kuo  C-C, Grayston  JT, Campbell  LA. Evidence of systemic dissemination of C. pneumoniae infection via macrophages in the mouse. J Infect Dis. 1998;177:13225. DOIPubMedGoogle Scholar
  36. Fryer  RH, Schwobe  EP, Woods  ML, Rodgers  GM. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Investig Med. 1997;45:16874.PubMedGoogle Scholar
  37. Molestina  RE, Dean  D, Ramirez  JA, Summersgill  JT. Characterization of a strain Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells. Infect Immun. 1998;66:136076.
  38. Kaukoranta-Rolvanen  SS, Ronni  T, Leinonen  M, Saikku  P, Laitinen  K. Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb Pathog. 1996;21:40711. DOIPubMedGoogle Scholar
  39. Heinemann  M, Susa  M, Simnacher  U, Marre  R, Essig  A. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun. 1996;64:487287.PubMedGoogle Scholar
  40. Fong  IW, Chiu  B, Viira  E, Fong  MW, Jang  D, Mahony  J. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol. 1997;35:4852.PubMedGoogle Scholar
  41. Laitinen  K, Laurila  A, Pyhala  L, Leinonen  M, Saikku  P. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun. 1997;65:48325.PubMedGoogle Scholar
  42. Moazed  TC, Kuo  C-C, Grayston  JT, Campbell  LA. Murine Models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis. 1997;175:88390. DOIPubMedGoogle Scholar
  43. Moazed  TC, Campbell  LA, Rosenfeld  ME, Grayston  JT, Kuo  C-C. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in ApoE-deficient mice. In: Stephens RS, Byrne GI, Christiansen G, Clark I, Grayston JT, Hatch T, et al., editors. Chlamydial Infections-1998: Proceedings of the 9th International Symposium on Human Chlamydial Infections; 1998 Jun 21-26; Napa, California. In Press 1998.
  44. Malinverni  R, Kuo  C-C, Campbell  LA, Grayston  JT. Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. J Infect Dis. 1995;172:5934.PubMedGoogle Scholar
  45. Laitinen  K, Laurila  AL, Leinonen  M, Saikku  P. Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment. Infect Immun. 1996;:148890.PubMedGoogle Scholar
  46. Malinverni  R, Kuo  C-C, Campbell  LA, Lee  A, Grayston  JT. Experimental Chlamydia pneumoniae (TWAR) pneumonitis: effect of two antibiotic regimens on the course and persistence of infection. Antimicrob Agents Chemother. 1995;39:459.PubMedGoogle Scholar
  47. Muhlestein  JB, Anderson  JL, Hammond  EH, Zhao  L, Trehan  S, Schwobe  EP, Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 1998;97:6336.PubMedGoogle Scholar
  48. Gupta  S, Leatham  EW, Carrington  D, Mendell  MA, Kaski  JC, Camm  AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation. 1997;46:4047.
  49. Gurfinkel  E, Bozovich  G, Daroca  A, Beck  E, Mautner  B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet. 1997;350:4047. DOIPubMedGoogle Scholar
  50. Jackson  LA, Wang  S-P, Douglas  K, Cooke  DB, Grayston  JT. Azithromycin treatment following percutaneous coronary revascularization procedures: a pilot study. Detection of Chlamydia pneumoniae bacteremia in patients with symptomatic coronary atherosclerosis. In: Abstracts of the 4th International Conference on the Macrolides, Azalides, Streptogramins and Ketolides; 1998; Barcelona, Spain. 1998; Abstract 4.16.
  51. Grayston  JT. Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events [editorial]. Circulation. 1998;97:166970.PubMedGoogle Scholar
  52. Muhlestein  JB, Carlquist  JF, Hammond  EH, Radicke  E, Thomson  MJ, Trehan  C, Detection of Chlamydia pneumoniae in patients with symptomatic coronary atherosclerosis [abstract]. J Investig Med.;45:142A.

Main Article

Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.